Thinking about buying stock in Celyad Oncology, Calyxt, IQIYI, Vinco Ventures, or Carvana?Jan 17, 2023
Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual propertyDec 21, 2022
Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business HighlightsNov 10, 2022
Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations TransactionSep 20, 2022
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business HighlightsMay 5, 2022